Kura Oncology Announces Positive Phase 1 Kidney Cancer Data
SAN DIEGO – July 27, 2026 Kura Oncology, Inc. has reported updated Phase 1a clinical data from the ongoing...
ADC AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SAN DIEGO – July 27, 2026 Kura Oncology, Inc. has reported updated Phase 1a clinical data from the ongoing...
SAN DIEGO, July 14, 2026 Kura Oncology announced that updated long-term follow-up data from the ongoing FIT-001 Phase 1a...
